Table 3.

Outcome Difference After Treatment.

Outcome	Treatment group (N = 11)	Control group (N = 11)	P a
ISI
Baseline	18.0 [15.0 to 22.0]	16.0 [13.0 to 21.0]
Week 2	12.5 [10.0 to 20.0]	12.0 [9.0 to 16.0]
Difference	−4.0 [−7.0 to −2.0]	−3.0 [−6.0 to 0.0]	.5507
Pb	.0137	.0430
Week 4	7.0 [6.0 to 13.0]	10.0 [8.0 to 14.0]
Difference	−8.5 [−12.0 to −5.0]	−6.5 [−10.0 to −3.0]	.2266
Pb	.0059*	.0059*
PSQI
Baseline	15.0 [10.0 to 17.0]	13.0 [12.0 to 17.0]
Week 4	7.0 [4.0 to 12.0]	10.5 [8.0 to 13.0]
Difference	−7.5 [−9.0 to −5.0]	−3.5 [−5.0 to −2.0]	.0782
Pb	.0059*	.0039*
ESS
Baseline	10.0 [5.0 to 16.0]	6.0 [3.0 to 13.0]
Week 4	5.0 [3.0 to 7.0]	4.0 [3.0 to 5.0]
Difference	−4.0 [−9.0 to 1.0]	−1.0 [−3.0 to 4.0]	.4578
Pb	.0879	.7266
SAS
Baseline	38.0 [36.0 to 47.0]	38.0 [32.0 to 44.0]
Week 4	33.0 [29.0 to 38.0]	39.0 [34.0 to 45.0]
Difference	−7.5 [−9.0 to −4.0]	2.0 [−2.0 to 5.0]	.0069*
Pb	.0059*	.2070
BFI
Baseline	4.8 [3.0 to, 5.1]	3.8 [3.3 to 4.9]
Week 4	2.1 [1.6 to 3.6]	2.5 [2.0 to 4.1]
Difference	−1.5 [−2.3 to −1.2]	−0.8 [−1.3 to −0.1]	.0796
Pb	.0020*	.0840
EQ-5D
Baseline	0.86 [0.83 to 0.88]	0.83 [0.80 to 0.87]
Week 4	0.87 [0.83 to 1.00]	0.85 [0.80 to 0.87]
Difference	0.00 [−0.03 to 0.05]	0.00 [−0.13 to 0.01]	.3893
Pb	.6719	.6875

Abbreviations: ISI, Insomnia Severity Index; PSQI, Pittsburgh Sleep Quality Index; ESS, Epworth Sleepiness Scale; SAS, Zung Self-Rating Anxiety Scale; BFI, Brief Fatigue Inventory; EQ-5D, Euroqol-5 Dimensions.

^aWilcoxon rank sum test.

^bWilcoxon signed rank test Median [Q1-Q3].

^*P < .05.